Pharmaceutical Technology Europe
It's been a while since I last wrote my last editor's comment - a combination, during the last few months, of attending a variety of industry events (as the conference and exhibition season peaked before the summer) and being on holiday. I apologize for the poor excuses, but it's certainly better than saying the dog ate my homework.
It's been a while since I last wrote my last editor's comment — a combination, during the last few months, of attending a variety of industry events (as the conference and exhibition season peaked before the summer) and being on holiday. I apologize for the poor excuses, but it's certainly better than saying the dog ate my homework.
Gurminder Marwaha
I'd like to thank all those who participated in our annual readership survey a couple of months ago; your input and feedback is essential in helping us maintain Pharmaceutical Technology Europe (PTE) as the authoritative voice of the pharmaceutical industry. It's rewarding to know that we are providing the right balance of editorial and your comments will help us shape the magazine in 2007. Next year will see increased coverage of outsourcing and biopharmaceuticals — two key areas in this industry and, judging by your comments, ones that should be encompassed within PTE. And I must not forget to congratulate Nigel Miller of sanofi-aventis, who wins a Sony PSP for being picked out in the survey prize draw.
Already we're into September and it means there's only a few weeks to go until the CPhI expo in Paris. The show will see us launch our new electronic magazine, Pharmaceutical Technologist — a fully interactive digital publication that will offer a global insight with market analysis, showcase the latest industry trends, and offer commentary and opinions from leading people in the sector. And because it's available online in both live and downloadable easy-to-read formats, you'll always be able to keep up-to-date with what's happening in the industry at a time that suits you. If you'd like to contribute to this exciting reading experience, then just drop me an email at the address below.
We'll be sending out more information in due course, but if you would like to see Pharmaceutical Technologist in action, then drop by our stand at CPhI (Hall 5, Stand 5M39), where we'll have the launch issue set up and ready for you to view. We look forward to seeing you in Paris.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy
March 25th 2025Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.